Goelzer Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Sell |
1,147
-40
| -3% | -$16.2K | 0.03% | 195 |
|
|
2025
Q1 | $591K | Buy |
1,187
+368
| +45% | +$183K | 0.03% | 169 |
|
|
2024
Q4 | $426K | Buy |
819
+42
| +5% | +$21.9K | 0.02% | 189 |
|
|
2024
Q3 | $481K | Sell |
777
-35
| -4% | -$21.7K | 0.03% | 180 |
|
|
2024
Q2 | $449K | Sell |
812
-3,053
| -79% | -$1.69M | 0.03% | 179 |
|
|
2024
Q1 | $2.25M | Sell |
3,865
-264
| -6% | -$153K | 0.13% | 124 |
|
|
2023
Q4 | $2.19M | Buy |
4,129
+70
| +2% | +$37.2K | 0.14% | 122 |
|
|
2023
Q3 | $2.05M | Sell |
4,059
-56
| -1% | -$28.3K | 0.14% | 116 |
|
|
2023
Q2 | $2.15M | Buy |
4,115
+1,410
| +52% | +$736K | 0.18% | 116 |
|
|
2023
Q1 | $1.56M | Sell |
2,705
-76
| -3% | -$43.8K | 0.14% | 132 |
|
|
2022
Q4 | $1.53M | Sell |
2,781
-77
| -3% | -$42.4K | 0.13% | 137 |
|
|
2022
Q3 | $1.45M | Buy |
2,858
+313
| +12% | +$159K | 0.14% | 135 |
|
|
2022
Q2 | $1.38M | Buy |
2,545
+92
| +4% | +$50K | 0.13% | 139 |
|
|
2022
Q1 | $1.45M | Buy |
2,453
+135
| +6% | +$79.7K | 0.13% | 144 |
|
|
2021
Q4 | $1.55M | Buy |
2,318
+24
| +1% | +$16K | 0.13% | 149 |
|
|
2021
Q3 | $1.31M | Sell |
2,294
-61
| -3% | -$34.9K | 0.11% | 151 |
|
|
2021
Q2 | $1.19M | Buy |
2,355
+69
| +3% | +$34.8K | 0.1% | 158 |
|
|
2021
Q1 | $1.04M | Sell |
2,286
-131
| -5% | -$59.8K | 0.09% | 156 |
|
|
2020
Q4 | $1.13M | Buy |
2,417
+17
| +0.7% | +$7.92K | 0.1% | 152 |
|
|
2020
Q3 | $1.06M | Buy |
2,400
+35
| +1% | +$15.5K | 0.1% | 158 |
|
|
2020
Q2 | $857K | Buy |
2,365
+151
| +7% | +$54.7K | 0.08% | 160 |
|
|
2020
Q1 | $628K | Buy |
+2,214
| New | +$628K | 0.07% | 175 |
|